The long latency of cancer initiation and development implies that additional genetic and/or epigenetic alterations likely take place in the liver in the absence of Pten. It remains elusive for the role of Pten loss in HBV-associated liver cancer initiation and progression. The gene discussed is PTEN; the disease is liver cancer.